3D Bioprinting Market Insights 2019 | Prominent Factors by Industry Size, Share, Business Development Plans and Forecast to 2024


Report Titled: “3D Bioprinting Market – Growth, Trends and Forecasts (2019 – 2024)

The Research Report on “3D Bioprinting Market” 2019 report includes every aspect of the 3D Bioprinting industry along with the progress performance. 3D Bioprinting Market report presents an analysis of market size, share, and growth, trends, and price structure, statistical and detailed data of the 3D Bioprinting industry. Additionally, 3D Bioprinting Market 2019 research report offers key analysis on the industry status of the 3D Bioprinting producers with market size, growth, share, trends as well as business price structure.

The 3D Bioprinting Market report is a professional and detailed study on the 3D Bioprinting business. 3D Bioprinting market to predict future market directions between the forecast periods from 2019 to 2024 providing you with vital data for your business decisions.

Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/13999778

Scope of the Report:

  • 3D bioprinting is an emerging field represented by various biologically applied deposition and assembling systems, which include direct writing, photolithography, microstamping, extrusion, laser writing, stereolithography, electro-printing, microfluidics, and inkjet deposition.<

    Market Overview:

  • The Global 3D Bioprinting Market was valued at USD 385.56 million in 2018 and is expected to register a CAGR of 25.36% during the forecast period (2019-2024). The global 3D bioprinting market is expected to grow, owing to its revolutionary breakthrough in healthcare and pharmaceutical industries. The increasing technological advancements, government intervention for improving healthcare, and increasing investments in R&D are also significant factors driving the studied market growth.
  • The primarily growing bioprinting applications include 3D bioprinted tissue and hair follicles, as they are very beneficial to cosmetics companies, especially in Europe, where animal testing for cosmetics was banned in 2013. For a cosmetic company, the advantage will be the ability to economically and ethically test products (i.e., not on animals) across varying skin types, for more accurate results.
  • Growing government support is also attracting many investors to invest in R&D programs, which is expected to develop space for the studied market. In 2018, Mapp Biopharmaceutical Inc. announced that it had been awarded a contract of USD14.8 million, with options for an additional USD 32.0 million, by the Biomedical Advanced Research and Development Authority (BARDA).
  • Further, a significant increase in the number of older adults is projected in the coming decades, which is expected to drive the need for 3D bioprinting reflecting the growth of the market.

    3D Bioprinting Report Also Covers Offer for New Project Includes:

    • Market Entry Strategies
    • Countermeasures of Economic Impact
    • Marketing Channels
    • Feasibility Studies of New Project Investment
    • Research Conclusions of the 3D Bioprinting Industry

    The report provides key statistics on the market status of the 3D Bioprinting Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the 3D Bioprinting.

    Enquire Before Purchasing this Report – https://www.industryresearch.co/enquiry/pre-order-enquiry/13999778

    3D Bioprinting Market Report Also Covers Marketing Strategy Analysis, Top Manufacturers:

  • 3D Systems Corporation
  • Aspect Biosystems Ltd
  • GeSIM GmbH
  • Bio3D Technologies
  • Allevi Inc.
  • Cyfuse Biomedical KK
  • Envision TEC GmbH
  • Organovo Holdings Inc.
  • 3Dynamic Systems Ltd
  • RegenHU SA
  • Stratasys Ltd
  • REGEMAT 3D
  • 3D Bioprinting Solutions
  • Arcam AB (GE Company)

    Key Market Trends:

    Drug Testing to Hold Major Share

    3D bioprinters are of the highest importance for drug testing and clinical trials applications expected to drastically reduce the need for animal trials (therefore not only being ethically beneficial but also being cost-effective).

    Traditionally, clinical trials for new drug development involved testing on animals with artificially induced affected tissues. With the advent of 3D bioprinting, drug developers will be able to address the complications associated with human clinical trials of new drugs, by identifying them in a short period (since these can be tested with human-like 3D printed tissues).

    Thus, they are expected to reduce the losses incurred during late-stage failures. The regulatory agency of the United States Food and Drug Administration has already started to consider integrating alternatives for drug safety and efficacy assessment, providing scope for the market. Companies like Organovo (US based) were instrumental in the development of 3D bioprinter able to develop liver and kidney tissue for drug discovery applications.

    Cosmetic companies are also potential buyers of the bioprinter technology. In 2013, the European Union prohibited the use of cosmetics developed by animal testing. Prohibition of retailing products tested abroad on animals was also levied. Such regulations have accelerated the use of alternatives like bioprinting.

    Asia-Pacific Anticipated to Witness Fastest Growth

    Asia-Pacific is the fastest growing market for 3D bioprinting, mainly due to a strong existing consumer base that will drive demand for 3D bioprinting, huge scope of 3D printing in medical services, increasing R&D for 3D printing, and government support and tax incentives. The growing number of cancer cases and the increasing the number of cancer treatments in the region are also expected to fuel the adoption of 3D bioprinting technology. According to the World Cancer Research Fund, the cancer rate is the highest in Australia and New Zealand in the world.

    Purchase this Report (Price 4250 USD for Single User License) – https://www.industryresearch.co/purchase/13999778

    Detailed TOC of 3D Bioprinting Market Report are:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY
    2.1 Analysis Methodology
    2.2 Research Phases

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Introduction to Market Drivers and Restraints
    4.3 Market Drivers
    4.3.1 Increasing Geriatric Population
    4.3.2 Increasing Organ Transplant Requirements
    4.3.3 Increasing Investments In R&D
    4.4 Market Restraints
    4.4.1 Operational Challenges
    4.5 Industry Attractiveness Porter’s Five Force Analysis
    4.5.1 Threat of New Entrants
    4.5.2 Bargaining Power of Buyers/Consumers
    4.5.3 Bargaining Power of Suppliers
    4.5.4 Threat of Substitute Products
    4.5.5 Intensity of Competitive Rivalry
    4.6 Industry Value Chain Analysis

    5 MARKET SEGMENTATION
    5.1 By Technology
    5.1.1 Syringe/Extrusion Bioprinting
    5.1.2 Inkjet Bioprinting
    5.1.3 Magnetic Levitation Bioprinting
    5.1.4 Laser-assisted Bioprinting
    5.1.5 Other Technologies
    5.2 By Component
    5.2.1 3D Bioprinters
    5.2.2 Biomaterials
    5.2.3 Scaffolds
    5.3 By Application
    5.3.1 Drug Testing and Development
    5.3.2 Regenerative Medicine
    5.3.3 Food testing
    5.3.4 Research
    5.3.5 Other Applications
    5.4 Geography
    5.4.1 North America
    5.4.1.1 US
    5.4.1.2 Canada
    5.4.2 Europe
    5.4.2.1 Germany
    5.4.2.2 UK
    5.4.2.3 France
    5.4.2.4 Rest of Europe
    5.4.3 Asia-Pacific
    5.4.3.1 China
    5.4.3.2 Japan
    5.4.3.3 India
    5.4.3.4 Rest of Asia-Pacific
    5.4.4 Rest of World
    5.4.4.1 Lain America
    5.4.4.2 Middle East & Africa

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 3D Systems Corporation
    6.1.2 Aspect Biosystems Ltd
    6.1.3 GeSIM GmbH
    6.1.4 Bio3D Technologies
    6.1.5 Allevi Inc.
    6.1.6 Cyfuse Biomedical KK
    6.1.7 Envision TEC GmbH
    6.1.8 Organovo Holdings Inc.
    6.1.9 3Dynamic Systems Ltd
    6.1.10 RegenHU SA
    6.1.11 Stratasys Ltd
    6.1.12 REGEMAT 3D
    6.1.13 3D Bioprinting Solutions
    6.1.14 Arcam AB (GE Company)

    7 INVESTMENT ANALYSIS

    8 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Laptop Case Market 2019: Global Industry Current Trends, Top Companies, Application, Growth Factors, Development and Forecast to 2024 Research Report

    Corset Market Report 2019 Analysis by Market Players, Size, Share, Growth Rate, Opportunities, Drivers, and Risk Factor Forecast to 2022

    NTP Time Server Market 2019 Outlook by Import, Export, Consumption and Consumption Value by Major Countries and Key Players Forecast to 2025



  • Source link

    Leave a Reply